Kari Kendra
- Oncology top 2%
- Molecular Biology top 10%
- Immunology top 5%
- Genetics top 5%
- Pulmonary and Respiratory Medicine top 10%
- Co-authors
- Benita S. KatzenellenbogenYolande BerthoisWilliam E. CarsonGregory B. LesinskiMichael J. WalkerDwight H. OwenThomas OlenckiGregory A. Otterson
- Topics
- Cancer Immunotherapy and Biomarkers (51 papers)Melanoma and MAPK Pathways (30 papers)CAR-T cell therapy research (21 papers)
- Cited by
- OncologyImmunologyGenetics
- Journals
- Nature MedicineJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- United StatesCanadaItaly
In The Last Decade
Kari Kendra
108 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 97
- Oncology 1.5k
- Molecular Biology 1.1k
- Immunology 600
- Genetics 474
- Pulmonary and Respiratory Medicine 319
Countries citing papers authored by Kari Kendra
This map shows the geographic impact of Kari Kendra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kari Kendra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kari Kendra more than expected).
Fields of papers citing papers by Kari Kendra
This network shows the impact of papers produced by Kari Kendra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kari Kendra. The network helps show where Kari Kendra may publish in the future.
Co-authorship network of co-authors of Kari Kendra
This figure shows the co-authorship network connecting the top 25 collaborators of Kari Kendra. A scholar is included among the top collaborators of Kari Kendra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kari Kendra. Kari Kendra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 1 | |
| 5 | 4 | |
| 6 | 1 | |
| 7 | 7 | |
| 8 | 4 | |
| 9 | 2 | |
| 10 | 82 | |
| 11 | 30 | |
| 12 | Identification of novel targeted therapies for BAP1 mutated tumors | 1 |
| 13 | 23 | |
| 14 | Ocular side effects of novel and traditional chemotherapeutic agents | 0 |
| 15 | Ocular side effects of traditional chemotherapeutics and small molecule inhibitors | 0 |
| 16 | 21 | |
| 17 | 28 | |
| 18 | A STUDY OF THE EFFECTS OF INHIBITION OF CYP3A4 BY KETOCONAZOLE (K) AND CYP2C8 BY GEMFIBROZIL (G) ON THE PHARMACOKINETICS DABRAFENIB (D) | 3 |
| 19 | 27 | |
| 20 | 118 |
About Kari Kendra
Kari Kendra is a scholar working on Oncology, Immunology and Geriatrics and Gerontology, having authored 119 papers that have together received 2.5k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (51 papers), Melanoma and MAPK Pathways (30 papers) and CAR-T cell therapy research (21 papers). The work is most often cited by research in Oncology (1.5k citations), Immunology (600 citations) and Genetics (474 citations). Kari Kendra has collaborated with scholars based in United States, Canada and Italy. Frequent co-authors include Benita S. Katzenellenbogen, Yolande Berthois, William E. Carson, Gregory B. Lesinski, Michael J. Walker, Dwight H. Owen, Thomas Olencki, Gregory A. Otterson, Helen X. Chen and Kimberly A. Varker. Their work appears in journals such as Nature Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.